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Background: To develop age- and sex-standardised scores for the Parent Report of 
Children’s Abilities-Revised (PARCA-R) in order to assess children’s cognitive and language 
development at 24 to 27 months of age. 
Methods: Anonymised data from PARCA-R questionnaires completed by parents of 2 year-
old children in three previous studies were obtained to form a standardisation sample 
(n=6402) representative of the UK general population. Anonymised data were obtained from 
three further studies to assess the external validity (n=709) and clinical validity (n=1456) of 
the standardised scores. The L(lamda)M(mu)S(sigma) method was used to develop age- and 
sex-specific standardised scores for three scales (non-verbal cognitive development; language 
development; total Parent Report Composite (PRC)) for children in four 1-month age bands 
spanning 23·5 to 27·5 months of age. 
Findings: For all PARCA-R scales, mean (SD) standardised scores approximated 100 (15) in 
both sexes and all age groups. These were independent of socio-economic status. 
Standardised scores were close to 100 (15) in the external validation sample, demonstrating 
the validity of the scores. Children born very preterm or with neonatal sepsis had, 
respectively, standardised scores for the total PRC scale 0.47 SD and 0.73 SD lower on 
average than the normative mean. These were equivalent to a standardised score of 93 (95% 
Confidence interval (CI): 91 to 94) and 89 (95% CI: 88 to 91) respectively, thus 
demonstrating clinical validity. 
Interpretation: The PARCA-R provides a norm-referenced, standardised assessment of 
cognitive and language development at 24-27 months of age. The questionnaire is available 
non-commercially with translations currently available in 14 languages, thus providing 
clinicians and researchers with a cost-effective tool for assessing development and 
identifying children with delay. 
Funding: This study was funded by Action Medical Research (Ref: GN2580).  
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Increased awareness of the long term effects of early life events has highlighted the 
importance of early childhood development for future health and wellbeing. Intervention 
offered in the first three years of life, during a period of rapid brain maturation, may have 
lifelong effects on development.1 As such, identifying children at risk of developmental delay 
is crucial to ensure they receive timely intervention to promote their development and reduce 
the risk of long term disability.2 Developmental screening in early childhood is therefore a 
central tenet of healthcare systems worldwide.2-4  
 
Valid and reliable norm-referenced measures are needed to assess development and screen 
for delay in early childhood. This is particularly the case for identifying children with delayed 
cognitive and language development, for which routine clinical assessments lack sensitivity.5 
The Parent Report of Children’s Abilities-Revised (PARCA-R)6 is a brief questionnaire that 
takes 10-15 minutes for parents to complete to assess cognitive and language development at 
24 months of age. The PARCA-R has concurrent validity with examiner administered 
developmental tests6-9 and excellent test-retest reliability.6 Cut-off scores with diagnostic 
utility for identifying children with moderate to severe developmental delay have also been 
derived from studies of clinical populations at high risk for developmental disorders.6-8 10-12 
The PARCA-R is widely used as an outcome measure in observational studies and clinical 
trials13-18 and is recommended for routine use in the UK to screen for developmental delay in 
children born preterm.19 To date, it has been translated into 14 languages and has been 
validated for use in Italian11 and Dutch9 and in samples in Australia and New Zealand.8 10 
 
Although cut-off scores exist for identifying children at risk of delay, these were derived 
from small studies resulting in wide confidence intervals around cut-points and with cut-off 
scores that vary widely between different populations.6 7 11 12  Moreover, these are only 
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available for identifying children with moderate to severe delay in clinical populations. The 
utility of the PARCA-R for assessing cognitive and language development of children across 
the whole developmental spectrum in the general population has not yet been explored. At 
present, there are no standardised scores for comparing a child’s developmental level with 
that of the norm. This limits the ability of the PARCA-R to identify children with subtle 
delays and to quantify progress across the full spectrum of development, thus limiting its use 
as a continuous outcome measure and as a universal screening tool.  
 
The aim of this study was to standardise the PARCA-R to enable professionals to precisely 
quantify a child’s developmental level and identify advanced development or delays of any 
severity among children in the general population. The objectives of the study were to: (1) 
develop age- and sex-standardised PARCA-R scores; (2) assess the external validity of the 
standardised scores; (3) assess the clinical validity of the standardised scores.  
 
Methods 
Standardisation sample 
Anonymised data from multiple studies were obtained in order to produce a standardisation 
sample representative of the UK general population in sex, gestational age, multiple birth, 
ethnicity and socio-economic status. The standardisation sample comprised completed 
PARCA-R questionnaires for 6196 children assessed at 2 years of age and born between 2010 
and 2013 to mothers participating in the INFANT randomised controlled trial of 
computerised interpretation of fetal heart rate during labour.13 As this sample was not 
representative of the gestational age range of births in the general population due to the small 
proportion (2·5%) of children born preterm (<37+0 weeks’ gestation), the standardisation 
sample was supplemented using anonymised data from two other studies. These additional 
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data included 186 randomly selected 2-year-old children born at 32+0 to 36+6 weeks’ gestation 
between 2009-2010 whose parents completed the PARCA-R for the Late and Moderately 
Preterm Birth Study (LAMBS)14, and 20 children born at 27+0 to 31+6 weeks of gestation 
between 2009-2011 whose parents completed the PARCA-R in the Preterm and After 
(PANDA) Study.20 Thus the total standardisation sample comprised anonymised data for 
6402 children. The distribution of sex, ethnicity (white vs. other) and quintiles of Index of 
Multiple Deprivation (IMD)21 scores for the standardisation sample were compared with data 
from the Office for National Statistics 2011 Census22, whilst the distribution of preterm and 
multiple births for the standardisation sample were compared with gestation specific birth 
data from the Office for National Statistics for England and Wales23 and from the Information 
Services Division for Scotland24 for children born in 2011.  
 
External validation sample 
To examine the external validity of the standardised scores, anonymised data from a sample 
of 709 children born at term (≥37+0 weeks’ gestation) whose parents completed the PARCA-
R for the LAMBS Study was used.14  
 
Clinical validation samples 
Given the well documented association of very preterm birth and neonatal sepsis with 
adverse neurodevelopmental outcomes, anonymised PARCA-R data from follow-up studies 
in these populations were used to examine the clinical validity of the standardised scores. 
First, to examine performance in a very preterm population, PARCA-R data from the 
remaining 692 children born <32+0 weeks of gestation in 2009-2011 in the PANDA study20 
were used. Second, PARCA-R data from 764 children with suspected or proven neonatal 
sepsis born in 2001-2007 in the UK arm of the International Neonatal Immunotherapy Study 
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(INIS)15 were used. Detailed information about these samples has been published 
previously.15,20  
 
Measures 
Cognitive and language development were assessed using the PARCA-R questionnaire 
completed by parents when children were as close as possible to 24 months chronological age 
(24 months corrected age for children born very preterm in the clinical validation samples). 
The PARCA-R comprises 34 forced choice items to assess non-verbal cognition, and a 100-
word vocabulary checklist and 18 forced-choice items to assess sentence complexity, the 
latter two of which comprised the UK short form adaptation of the MacArthur 
Communicative Development Inventories.25 Development of the PARCA-R has been detailed 
previously.6 26 The questionnaire and scoring instructions can be obtained from www.parca-
r.info. Summed scores for the two sub-scales of non-verbal cognition (NVC; range 0–34) and 
language development (range 0–124) were computed, and a total Parent Report Composite 
(PRC; range 0–158) score was computed by summing these sub-scale scores. Scores for 
missing questions in the NVC sub-scale were substituted with the average of the score for 
completed questions if ≤4 questions were missing; if >4 questions were missing the 
questionnaire was excluded from the analysis. Unchecked or unanswered items for the 
language sub-scale were set to zero.  
 
Statistical methods 
An extension of the LMS (Lambda for skewness, Mu for median, Sigma for the coefficient of 
variation (CV)) method27, with the implementation of the Beta-inflated distribution at 0 and 1 
that allows kurtosis to be modelled, was used to develop the standardised scores. Raw scores 
for each of the PARCA-R sub-scales and the total PRC score in the standardisation sample 
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were regressed against chronological age, separately for males and females. The predicted 
values of the median along with the CV, the skewness and the kurtosis, were used to calculate 
the cumulative distribution function and convert the raw PARCA-R scores to z-scores, which 
are normally distributed with a mean (SD) of 0 (1). The z-scores were then standardised to a 
mean (SD) of 100 (15) in keeping with standard psychometric tests using the formulae: 
100+z-score*15. Norms tables were then produced for obtaining standardised scores from 
PARCA-R raw scores separately for males and females for 4 age bands (23 months (mo) 16 
days (d) to 24mo 15d; 24mo 16d to 25mo 15d; 25mo 16d to 26mo 15d; 26mo 16d to 27mo 
15d) using the z-score corresponding to the mid-point of each age band (i.e. 24 months; 25 
months; 26 months; 27 months). 
 
To evaluate the external validity of the standardised scores when applied to a different 
population, the equations derived from the LMS models in the standardisation sample were 
applied to the PARCA-R data in the external validation sample. Using these equations, z-
scores were calculated and rescaled to a mean (SD) of 100 (15). External validity of the 
standardised scores would be demonstrated if the observed mean (SD) in the external 
validation sample is close to the expected mean (SD) of 100 (15) (or mean 0 (SD 1) in z-
scores). In addition, standardised scores for the PARCA-R data in the external validation 
sample were assigned using the norms tables (see Tables S8 to S15, supplementary 
appendix). If the standardised scores from the two methods are similar this will confirm the 
appropriateness of the norms tables for deriving the standardised scores in clinical practice.   
 
To evaluate the clinical validity of the standardised scores, the equations derived from the 
LMS models in the standardisation sample were applied to the PARCA-R data in the two 
clinical validation samples. Given the high risk for neurodevelopmental disabilities among 
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these populations, the mean standardised scores would be expected to be less than 100. For 
these samples, standardised scores were derived using corrected rather than chronological age 
as is conventional when assessing very preterm-born children.    
 
All analyses were performed using R version 3.4.328 incorporating the package “gamlss”29 to 
perform the LMS modelling and calculate centiles. Detailed information on the methodology 
for the development of the standardised scores can be found elsewhere (manuscript currently 
under review). The study was approved by the University of Leicester Research Ethics Sub-
Committee for Medicine and Biological Sciences (Ref: 13832). 
 
Role of funding source 
This study was funded by Action Medical Research (Ref: GN2580). The study sponsor had 
no role in study design, data collection, data analysis, data interpretation, or writing of the 
report. The corresponding author had full access to all the data in the study and had final 
responsibility for the decision to submit for publication. 
 
Results 
Representativeness of the standardisation sample 
Characteristics of the standardisation sample and that of the general population are shown in 
Table 1. Children were assessed at a mean age of 25 months 1 day (range: 23mo 16d to 27mo 
15d). The standardisation sample was representative of the general population in terms of 
sex, IMD, and multiple births, however it was not possible to determine representativeness of 
ethnicity as this was not recorded for 14% of children. Although the proportion of very 
preterm born children in the standardisation sample was less than in the general population 
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overall, this was only amongst the youngest age groups; the proportion in the oldest age 
groups matched that of the general population (Table S1, supplementary appendix). 
INSERT TABLE 1 
 
Development of the standardised scores 
For the total standardisation sample, sex-specific z-scores calculated from the LMS models 
approximated 0 (1) with 95% of data points within the [-2, +2] z-score range for each scale, 
indicating a good model fit. In addition, the fit was good in each age group as the mean z-
scores were very close to the expected mean (SD) of 0 (1), although the spread of the data 
was slightly wider than expected in the older age groups (Table 2).  
INSERT TABLE 2 
 
For all scales, in both sexes and all age groups, mean (SD) predicted raw scores were very 
close to the mean (SD) raw scores observed in the data, and the mean (SD) standardised 
scores were all close to 100 (15) (Table 3). Although mean standardised scores tended to 
increase with lower deprivation in both sexes, differences between IMD quintiles were not 
statistically significant (Table S2, supplementary appendix). The norms tables for deriving 
standardised scores from raw scores for use in clinical practice are provided in Tables S8 to 
S15 (supplementary appendix).  
 
Acknowledging that the proportion of preterm born children in the standardisation sample 
was approximately 1-3% less than in the UK population, depending on sex and age group, we 
also calculated the fitted centiles using corrected age instead of chronological age for these 
children. This resulted in a shift in the distribution of very preterm children which then 
matched the distribution in the UK population, however this did not affect the fitted centiles 
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which remained similar to those calculated using chronological age (data not shown), thus 
confirming validity of the standardised scores derived using chronological age.  
INSERT TABLE 3 
 
External validity of the standardised scores 
The external validity of the standardised scores was assessed in 709 term-born children at a 
mean age of 24 months 19 days (range: 23m 16d to 27mo 15d). This sample predominantly 
comprised children of white ethnic background (83%) who lived in the least deprived areas in 
the UK (44% in the 4th and 5th IMD quintile) (Table S3, supplementary appendix).  
 
The predicted raw scores using the equations derived from the standardisation sample were 
very similar to those observed in the external validation sample, demonstrating the external 
validity of the scores (Table 4). Moreover, the mean (SD) standardised scores approximated 
100 (15) for all scales and for the youngest age groups, whereas they show greater variation 
in the oldest age groups. The small differences in scores in the validation sample were 
expected and can be attributed to the differences in characteristics between the 
standardisation and validation samples and to differences in the distribution of the raw scores 
between the two samples.  
 
Moreover, the standardised scores generated from applying the equations derived from the 
standardisation process to the validation sample (as described above) matched very closely 
the standardised scores that were derived from the more simple process of using the norms 
tables (Tables S8 to S15, supplementary appendix). This demonstrates both the external 
validity of the scores and the accuracy of the norms tables for deriving the standardised 
scores in clinical practice. Any observed differences between the scores generated using the 
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two methods were of minor importance as they did not exceed 1 point and may be attributed 
to the small differences in the raw scores between the two samples (Tables S4 and S5, 
supplementary appendix).  
INSERT TABLE 4 
For 11% of males and 12% of females in the external validation sample, the main language 
spoken at home was not English. These children had similar standardised language and PRC 
scores to English speaking children, and slightly higher non-verbal cognitive scores, however 
the differences were not statistically significant (Table S6, supplementary appendix).  
 
Clinical validity of the standardised scores 
Clinical validity of the standardised scores was assessed in 692 children born very preterm 
(<32+0 weeks’ gestation) assessed at a mean corrected age of 24 months 9 days (range: 23mo 
16d to 27mo 14d) in the PANDA Study20 and 764 children with neonatal sepsis assessed at a 
mean corrected age of 24 months 8 days (range: 23mo 16d to 27mo 15d) in the INIS Study.15 
Characteristics of these participants are shown in Table S7 (supplementary appendix).  
 
Applying the equations derived from the LMS models in the standardisation sample to these 
clinical populations resulted in mean standardised scores that were significantly lower than 
the normative mean of 100 on all PARCA-R scales (Table 5). The mean PRC standardised 
score in the total PANDA sample was 7 (95% confidence interval (CI): -9 to -5) points lower 
than the normative mean, and in the total INIS sample was 10 (95% CI: -12 to -8) points 
lower. As shown in Table 5, the magnitude of the deficit differed by sex and age and between 
the two clinical populations. 
 INSERT TABLE 5 
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Discussion 
The newly developed standardised scores presented here make the PARCA-R a norm-
referenced measure that can be used to assess children’s cognitive and language 
development, separately and combined, at 24 to 27 months of age. As the validity and 
reliability of the PARCA-R have previously been demonstrated6 8 9 11, this study significantly 
advances the utility of the questionnaire as both a clinical assessment and as an outcome 
measure for research.  
 
Previous validation studies have derived cut-off scores for identifying children at risk for 
developmental delay and have reported high levels of sensitivity (> 80%).6-8 10 12 However, 
these studies have only developed cut-off scores for use in preterm populations and for 
identifying children at risk of moderate to severe developmental delay (scores > 2 SD below 
the mean on examiner administered tests), and in cognitive and language development 
combined. In addition, the relatively small samples sizes and the frequently reported low 
positive predictive values, which result in high rates of false positive screens or over-
referrals, have garnered concerns regarding the accuracy of these cut-off scores for use in 
clinical practice.  
 
Our development of the standardised scores addresses these issues allowing clinicians and 
researchers to precisely measure a child’s developmental level and classify delay of any 
severity relative to the norm. Commensurate with other psychometric tests, standardised 
scores were developed with a normative mean of 100 and SD of 15 and allow an assessment 
of development ranging from < -3SD to > +3SD. Professionals can therefore use the 
PARCA-R to aid in identifying children with either advanced or delayed cognitive and/or 
language development. This study also significantly improves the utility of the PARCA-R for 
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research by providing a continuous outcome measure that can be used to quantify 
development and detect small differences in development between individuals or groups of 
children.  
 
A developmental assessment carried out by a trained professional is typically considered the 
gold standard. However, the extensive resources required to administer such tests frequently 
prohibit their use on a large scale, particularly in low and middle income countries. As the 
PARCA-R is freely available for use, this provides a cost-effective standardised measure of 
children’s development and is thus a valid and reliable alternative to examiner administered 
tests. Indeed, in a recent systematic review the PARCA-R was identified as the best 
developmental screening tool for use with preterm children and was recommended for use to 
screen for developmental delay at 2 years corrected age in children born preterm.19 As 
development of the standardised scores extends the use of the PARCA-R as an assessment for 
all children in the general population, it could therefore be used for developmental 
surveillance in other clinical populations and in universal screening programmes. We are not 
aware of other parental assessments of cognitive and language development that have been 
age-standardised, not least in such a large sample. Moreover, the PARCA-R standardisation 
sample of 6402 children spanning 4 months of age far exceeds that of the current (3rd) edition 
of the Bayley Scales of Infant and Toddler Development which included up to 200 children 
across the same age range in the standardisation sample.30 We have also developed an online 
version of the questionnaire and a pre-programmed calculator for deriving the standardised 
scores (see www.parca-r.info). 
 
The strengths of this study lie in the development of an age- and sex- standardised parent 
report measure of cognitive and language development for use at two years of age, and the 
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large standardisation sample on which the normative data are based. Although data from 
three different studies had to be collated to form the standardisation sample, ultimately this 
was representative of the UK population in terms of sex, socio-economic status (IMD) and 
multiple births. We acknowledge that the ratio of children with white/other ethnic 
background was different compared with the UK population. However, there was no 
difference in mean standardised scores between children who did and did not come from 
homes in which English was the first language within the external validation sample, 
suggesting that the under-representation of children from non-white backgrounds may not 
have affected development of the standardised scores. In addition, despite collating data from 
multiple studies, the proportion of children born very preterm (<32 weeks’ gestation) was 
still under-represented in the two youngest age groups in the standardisation sample. This 
arose as a result of the PARCA-R being completed at 24 months corrected age for very 
preterm born children in the original studies, resulting in these children having generally 
higher chronological age at the time of their assessment. Nonetheless, whilst a sensitivity 
analysis conducted using corrected rather than chronological improved the distribution of 
preterm born children in the standardisation sample, it did not alter the fitted centiles and thus 
the standardised scores, therefore confirming the robustness of our results. As the PARCA-R 
was designed to assess development at 24 months of age, the age range within which it can 
be used is limited compared with other measures as standardised scores can only be obtained 
for children aged 24 to 27 months at the time of assessment. It is also important to note that 
standardised scores should be interpreted with caution for children aged 26 to 27 months 
given the smaller number in these groups in the standardisation sample. Finally, although the 
PARCA-R has been translated into 14 other languages to date (see www.parca-r.info), 
standardised scores have only been developed for the original English version in the UK 
population. Application of the standardised scores to other languages and populations could 
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be explored as the subject of future research. Moreover, whilst the concurrent validity of the 
PARCA-R has been established, a recommendation for research into the predictive validity of 
the PARCA-R for identifying children at risk for later learning difficulties and special 
educational has been made.19  
 
In summary, the PARCA-R provides an age- and sex-specific standardised assessment of 
children’s cognitive and language development at two years of age and can be used as a cost-
efficient developmental assessment for clinical and research purposes.  
 
Data sharing  
Individual participant data are not available for sharing. This study comprises secondary 
analysis of data from multiple sources, therefore the University of Leicester are not the 
custodians of the data. 
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Table 1: Distribution of socio-demographic and birth characteristics in the standardisation sample 
and the general populationa. 
  Standardisation 
sample 
General population Difference % (95% CI)    
Standardisation-UK 
Child’s sex, n (%) 6402 757686 
 
Male 3321 (51·9) 386833 (51·1) 0·8 (-0·4; 2·0) 
Female 3081 (48·1) 370853 (48·9) -0·8 (-2·0; 0·4) 
Ethnic background, n (%) 6402 3789571b 
 
White 5009 (78·2) 2956304 (78) 0·2 (-0·8; 1·2) 
Other 508 (7·9) 833267 (22) -14·1 (-14·7; -13·4) 
Missing 885 (13·8) - 13·8 (13·0; 14·7) 
IMD Quintiles, n (%) 6402 8012452 
 
1st Q (most deprived) 1651 (25·8) 2070160 (25·8) 0·0 (-1·1; 1·0) 
2nd Q 1284 (20·1) 1701987 (21·2) -1·2 (-2·2; -0·2) 
3rd Q 1081 (16·9) 1478481 (18·5) -1·6 (-2·5; -0·6) 
4th Q 1217 (19·0) 1370451 (17·1) 1·9 (0·9; 2·9) 
5th Q (least deprived) 1078 (16·8) 1391373 (17·4) -0·5 (-1·4; 0·4) 
Missing 91 (1·4) - 1·4 (1·1; 1·7) 
Preterm birth, n (%) 6402 772542 
 
Full term (37-42 weeks) 6039 (94·3) 717040 (92·8) 1·5 (0·9; 2·1) 
Late & moderately preterm (32-36 weeks) 343 (5·4) 45889 (5·9) -0·6 (-1·1; 0·0) 
Very preterm (<32 weeks) 20 (0·3) 9613 (1·2) -0·9 (-1·1; -0·8) 
Multiple birth, n (%) 6402 772750 
 
Singleton birth 6234 (97·4) 748281 (96·8) 0·5 (0·1; 0·9) 
Multiple birth 168 (2·6) 24469 (3·2) -0·5 (-0·9; -0·1) 
 
IMD: Index of Multiple Deprivation. a Distribution of sex, ethnicity and IMD quintiles obtained from the Office for National 
Statistics 2011 Census22; Distribution of preterm and multiple births obtained from the Office for National Statistics for 
England and Wales23 and from the Information Services Division for Scotland24 for children born in 2011. bThe 2011 Census 
refers to children aged 0-4 years.   
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Table 2: Mean (SD) of z-scores derived from modelling the PARCA-R non-verbal cognitive 
and language scales and the total PRC scale in the standardisation sample (n=6402) for males 
and females overall and by age group. 
  n Non-verbal 
cognition 
Language 
development 
Parent Report 
Composite 
Males     
Total 3321 0·003 (0·99) -0·006 (1·00) -0·008 (1·00) 
Age group, months     
23mo 16d to 24mo 15d 1136 -0·03 (0·94) -0·03 (0·98) -0·03 (0·99) 
24mo 16d to 25mo 15d 1395 0·02 (1·01) 0·001 (0·99) 0·002 (0·99) 
25mo 16d to 26mo 15d  570 0·04 (1·01) 0·04 (1·04) 0·02 (1·03) 
26mo 16d to 27mo 15d 220 -0·05 (0·98) -0·02 (1·08) -0·05 (1·05) 
Females     
Total 3081 -0·005 (0·99) 0·0003 (1·00) -0·003 (1·00) 
Age group, months     
23mo 16d to 24mo 15d 1049 -0·02 (0·98) 0·02 (1·00) 0·001 (1·00) 
24mo 16d to 25mo 15d 1329 -0·009 (0·99) 0·0005 (0·98) 0·002 (0·98) 
25mo 16d to 26mo 15d  511 0·03 (1·02) -0·04 (1·03) -0·02 (1·05) 
26mo 16d to 27mo 15d 192 0·02 (1·01) 0·002 (1·04) -0·03 (1·05) 
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Table 3: Mean (SD) PARCA-R raw and standardised scores for males and females by age group in the standardisation sample (n=6402).  
    Non-verbal cognitive Language development Parent Report Composite 
  
Raw score Standardised Raw score Standardised Raw score Standardised 
  n Observed Predicted score Observed Predicted score Observed Predicted score 
Males (n=3321)                     
Age group, months  
         
23mo 16d to 24mo 15d 1136 26·9 (3·5) 26·6 (6·9) 100 (14) 57 (31) 58 (29) 100 (15) 84 (33) 85 (36) 100 (15) 
24mo 16d to 25mo 15d 1395 27·4 (3·7) 27·3 (7·1) 100 (15) 62 (31) 62 (31) 100 (15) 89 (33) 90 (38) 100 (15) 
25mo 16d to 26mo 15d  570 27·8 (3·6) 27·7 (7·2) 101 (15) 66 (32) 65 (33) 100 (15) 93 (33) 94 (40) 100 (15) 
26mo 16d to 27mo 15d 220 27·8 (3·5) 27·8 (7·2) 99 (15) 65 (33) 67 (34) 100 (16) 93 (34) 95 (41) 99 (16) 
Females (n=3081)  
         
Age group, months  
         
23mo 16d to 24mo 15d 1049 28·1 (3·3) 27·8 (6·9) 100 (15) 73 (30) 71 (35) 100 (15) 102 (32) 100 (43) 100 (15) 
24mo 16d to 25mo 15d 1329 28·4 (3·3) 28·2 (7·0) 100 (15) 77 (29) 77 (38) 100 (15) 105 (31) 105 (45) 100 (15) 
25mo 16d to 26mo 15d  511 28·8 (3·3) 28·6 (7·1) 100 (15) 80 (31) 80 (39) 100 (16) 109 (32) 110 (47) 100 (16) 
26mo 16d to 27mo 15d 192 29·1 (3·0) 28·9 (7·2) 100 (15) 84 (31) 83 (41) 100 (16) 113 (32) 115 (49) 100 (16) 
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Table 4: Mean (SD) PARCA-R raw and standardised scores for males and females by age group, in the external validation sample (n=709). 
    Non-verbal cognitive Language development Parent Report Composite 
  
Raw score Standardised Raw score Standardised Raw score Standardised 
  n Observed Predicted score Observed Predicted score Observed Predicted score 
Males                     
Total 350 27·6 (3·6) 27·0 (7·0) 102 (15) 60 (32) 60 (30) 100 (16) 88 (33) 88 (38) 100 (15) 
Age group, months 
          
23mo 16d to 24mo 15d 184 27·4 (3·3) 26·7 (6·9) 102 (14) 58 (32) 58 (29) 100 (16) 86 (33) 85 (37) 101 (15) 
24mo 16d to 25mo 15d 128 27·8 (3·7) 27·2 (7·0) 102 (16) 61 (31) 62 (31) 100 (15) 89 (33) 89 (38) 100 (15) 
25mo 16d to 26mo 15d  25 27·4 (4·3) 27·6 (7·1) 99 (18) 58 (31) 65 (33) 98 (17) 86 (33) 93 (40) 97 (16) 
26mo 16d to 27mo 15d 13 28·2 (4·3) 27·8 (7·2) 102 (19) 79 (27) 67 (34) 106 (13) 107 (29) 95 (41) 105 (14) 
Females 
          
Total 359 28·4 (3·7) 28·6 (7·1) 101 (16) 73 (32) 74 (36) 99 (16) 101 (33) 103 (44) 99 (16) 
Age group, months 
          
23mo 16d to 24mo 15d 198 28·2 (4·0) 27·9 (6·9) 101 (16) 70 (31) 72 (35) 99 (16) 98 (33) 101 (43) 99 (16) 
24mo 16d to 25mo 15d 125 28·5 (3·3) 28·2 (7·0) 100 (15) 77 (32) 76 (37) 101 (16) 105 (33) 105 (45) 101 (16) 
25mo 16d to 26mo 15d  27 29·3 (3·5) 28·6 (7·1) 103 (18) 72 (31) 80 (40) 95 (17) 101 (33) 110 (47) 96 (16) 
26mo 16d to 27mo 15d 9 28·0 (2·9) 28·9 (7·1) 94 (14) 76 (36) 83 (41) 97 (17) 104 (37) 115 (49) 95 (17) 
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Table 5: PARCA-R standardised scores for males and females in the clinical validation samples. 
    Standardised score; mean (95% CI) 
    Non-verbal cognition Language development Parent Report Composite 
Males         
PANDA 
    
Total 342 91 (89; 93) 94 (93; 96) 94 (92; 96) 
Age group, months 
    
23mo 16d to 24mo 15d 234 92 (90; 94) 96 (94; 98) 96 (93; 98) 
24mo 16d to 25mo 15d 91 90 (86; 94) 91 (88; 95) 90 (86; 94) 
25mo 16d to 26mo 15d 14 81 (72; 91) 88 (78; 98) 88 (78; 98) 
26mo 16d to 27mo 15d 3 89 (69; 109) 89 (68; 110) 89 (67; 110) 
INIS 
    
Total 437 87 (85; 88) 89 (87; 91) 89 (87; 90) 
Age group, months 
    
23mo 16d to 24mo 15d 309 87 (85; 89) 89 (86; 91) 89 (86; 91) 
24mo 16d to 25mo 15d 88 87 (83; 91) 90 (86; 94) 90 (86; 94) 
25mo 16d to 26mo 15d 23 81 (73; 89) 88 (80; 96) 87 (79; 94) 
26mo 16d to 27mo 15d 17 89 (79; 98) 88 (79; 98) 89 (80; 97) 
Females 
    
PANDA 
    
Total 350 91 (89; 93) 92 (90; 94) 92 (90; 94) 
Age group, months 
    
23mo 16d to 24mo 15d 232 92 (89; 94) 93 (91; 96) 93 (91; 95) 
24mo 16d to 25mo 15d 96 89 (85; 93) 89 (86; 92) 89 (85; 92) 
25mo 16d to 26mo 15d 18 89 (80; 97) 88 (81; 96) 88 (80; 95) 
26mo 16d to 27mo 15d 4 88 (70; 106) 104 (88; 120) 101 (86; 117) 
INIS 
    
Total 327 87 (85; 89) 91 (89; 93) 90 (89; 92) 
Age group, months 
    
23mo 16d to 24mo 15d 237 90 (87; 92) 93 (91; 96) 92 (90; 95) 
24mo 16d to 25mo 15d 62 82 (76; 88) 86 (81; 91) 86 (81; 91) 
25mo 16d to 26mo 15d 17 79 (68; 90) 82 (72; 91) 81 (72; 91) 
26mo 16d to 27mo 15d 11 78 (64; 92) 89 (77; 101) 85 (73; 97) 
 
